Glenn’s unique background informs his legal practice; as a founder of a VC-backed pharmaceutical startup, as an academic inventor, as an industry scientist and as a patent attorney, Glenn understands intellectual property development from all sides.
Glenn has done a significant amount of work counseling startup companies operating in the area of protein therapeutics. In addition to patent drafting and prosecution for a range of clients from universities to large corporations, Glenn does freedom to operate analyses and validity and infringement opinion work.
In 2014, Glenn received his J.D. from University of Virginia School of Law. He was a member of the University of Virginia team at the 2013 National IP LawMeet Competition, which received the prize for best written brief.
Prior to becoming an associate at Bozicevic, Field & Francis, Glenn amassed five years valuable experience as a patent agent, including three years as an intellectual property consultant for Reflexion Pharmaceuticals, a San Francisco based startup.
Glenn was co-founder of a pharmaceutical startup where he worked closely with a university tech transfer office to establish sponsored research and license agreements for the company and with IP counsel to establish a patent portfolio. Previously, he worked as a Scientist for Somalogic, a biotechnology company developing a proteomics platform for clinical diagnostics.
Glenn was awarded a New Zealand FORST Postdoctoral Fellowship for research on DNA binding proteins at the University of Virginia. He received a Ph.D. in chemistry with an emphasis on the design and synthesis of HIV protease inhibitors and a B.Sc. with first class honors from the University of Canterbury in New Zealand.